Dublin, Jan. 21, 2019 (GLOBE NEWSWIRE) -- The "GCC In-Vitro Diagnostic Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023" report has been added to ResearchAndMarkets.com's offering.
The GCC in-vitro diagnostic devices market was worth US$ 1091 Million in 2017. The market is further projected to reach a value of US$ 1830 Million by 2023, at a CAGR of around 9% during 2018-2023.
There are various devices which can be used individually or in combinations with each other for in-vitro diagnosis including calibrators, specimen receptacles, reagents and control materials. In the GCC countries, there has been a rise in the demand for IVD devices on account of ageing population, rising prevalence of lifestyle diseases and a growth in the healthcare sector of the region. Apart from this, the market is also being impacted by the establishment of standalone centers, independent diagnostics chains and academic institutes.
GCC In-Vitro Diagnostic Devices Market Driver
The growth of the in-vitro diagnostic devices market in the region can be accounted to the easy access to better diagnostics and healthcare services facilitated by increasing insurance penetration under the Mandatory Health Insurance (MHI) schemes of the GCC countries.
The demand for in-vitro diagnostics devices has been driven by increasing health consciousness among the consumers. This has led to a hike in the number of people who seek diagnostic services at regular intervals for avoiding complexities in their health conditions. Additionally, consumers have increased their medical health spending owing to a rise in their disposable incomes which has further influenced the market growth.
The governments of the GCC countries have developed several health awareness programs and strategies. Along with this, they are also shifting their focus towards promoting specialized care and services, and increasing investments for the devices used in medical examinations.
Other factors that are driving this market include increasing prevalence of life style diseases, rising number of expatriates, increasing investments in healthcare infrastructure, etc.
Breakup by End-user:
The in-vitro diagnostic devices market has been segmented on the basis of various end-users including hospital-based centers, diagnostics chains, standalone centers, patient self-testing and academic institutes. Amongst these, in-vitro diagnostic devices are majorly used in hospital-based centers.
Breakup by Application:
The market has also been segmented on the basis of application. Some of the major applications covered in the report include Infectious diseases, diabetes, blood test, nephrology, cardiology, oncology and autoimmune diseases.
On a geographical front, Saudi Arabia enjoys the leading position in the GCC in-vitro diagnostic devices market. Other major regions include United Arab Emirates, Kuwait, Qatar, Oman and Bahrain.
Key Topics Covered:
2 Scope and Methodology
2.1 Objectives of the Study
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology
3 Executive Summary
4.2 Key Industry Trends
5 GCC In-Vitro Diagnostic Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Region
5.4 Market Breakup by End-User
5.5 Market Breakup by Application
5.6 Market Forecast
5.7 SWOT Analysis
5.8 Value Chain Analysis
5.8.2 Research and Development
5.8.3 Component Manufacturing
5.8.6 End-Use Industries
5.9 Porters Five Forces Analysis
6 Market Breakup by Region
6.1 Saudi Arabia
6.2 United Arab Emirates
7 Market Breakup by End-User
7.1 Hospital-Based Centres
7.2 Diagnostics Chains
7.3 Standalone Centres
8 Market Breakup by Application
8.1 Infectious Diseases
8.3 Blood Test
8.7 Autoimmune Diseases
9 Competitive Landscape
9.1 Market Structure
9.2 Key Players
For more information about this report visit https://www.researchandmarkets.com/research/gfmns8/gcc_1_83_billion?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: In Vitro Diagnostics